In addition QC6352 can also inhibit the expression of epidermal growth factor receptor (EGFR) (Metzger et al., 2017), which may explain the decrease in tumor-initiating cell populations associated with chemotherapy resistance (Chen et al., 2017). Here, EGFR is linked to neoplasm.